Update – this talk has been rescheduled to Tuesday July 28 at 11 a.m. in 110 Maryland Hall.
Johns Hopkins Institute for NanoBioTechnology presents Matthew J. Lesho, PhD, Biomedical Engineer with Northrop Grumman Electronic Systems for the final Professional Development Seminar for this summer. His talk, “Life after graduate school: Or lessons learned after 15 years in industry,” will be held July 22 Tuesday July 28 at 11 a.m. in 110 Maryland Hall Room B17 CSEB. This seminar is free and open to students, faculty, and staff.
Ever wonder what it might be like to work in industry for a small medical device start-up company or a large defense contractor? Learn from an expert with nearly 15 years in industry. Lesho will lead an interactive discussion that will highlight the similarities and differences of working in industry as compared to a career in academia. Lesho also will ask the audience to share their perceptions about what they think life will be like after graduation. This seminar provides some real world examples of product and technology development in the industrial environment to help students studying science and engineering gain some perspective on how their academic degrees could be applied to current medical, the military, or homeland defense challenges.
Lesho received his Bachelor’s, Master’s and Doctoral degrees in Biomedical Engineering from Johns Hopkins University. His master’s work involved studies of the microcirculation and his doctoral work used microfabrication technology and polymer science to develop biosensors based on electrochemically responsive hydrogels. He has over 14 years of industrial experience, including over seven years as at Cygnus, Inc., where he held increasingly responsible roles from technical contributor, manager, and associate director of efforts to develop, manufacture, gain FDA approval and market the first home-use non-invasive glucose monitor.
At Northrop Grumman, Lesho has held positions of biomedical engineer, project manager, program manager, and area manager for biodetection. Specific programs have involved development of next-generation instruments that detect and identify chemical and biological warfare agents, including the DARPA HISSS program. He is holder of eight patents in the area of glucose monitoring and processing of sensor data, three pending patent applications in the area of biological detection. He has a number of publications in fields of biosensors, clinical applications of medical sensors, and cellular physiology and has given invited talks in the areas of biodetection and nanotechnology for biosensing.
To attend this INBT Professional Development Seminar, please RSVP to Ashanti Edwards at email@example.com before July 21, 2009.
What is the DARPA HISSS program? http://www.darpa.mil/STO/chembio/hisss.html
Northrop Grumman Electronic Systems Website http://www.es.northropgrumman.com/